Polar Bear Genome opens its research and production plant in Leduc
By PLANT STAFF
Industry Production Food & Beverage Manufacturing biopharmaceutical manufacturing medicinal cannabis ResearchWill manufacture ingredient extracts and isolates, natural health and medicinal cannabis products.
Artist’s rendition of the completed Polar Bear Genome BioPharma Facility.
Photo: PBG Biopharma
LEDUC, Alta. — Polar Bear Genome (PBG) BioPharma Canada Corp. is officially opening its 25,000 square-foot research and manufacturing facility in Leduc, Alta. Aug. 8 where it will produce natural health and medicinal cannabis products.
The building’s offices will open for work as construction on the production area continues over the next nine to 12 months.
The facility will contain both a manufacturing and research/analytical lab to perform proprietary extractions, isolations, formulations and testing. Manufactured products will include ingredient extracts and isolates, and finished products.
Contract product development and manufacturing services will also be offered for Canadian and international businesses looking to create nutraceutical and medicinal cannabis products.
When the plant is up and running, the company says 50 new jobs will be created over the next three years.
PBG BioPharma is a biopharmaceutical company based in Alberta and Ontario.
